Personalized, parcel‐guided rTMS for the treatment of major depressive disorder: Safety and proof of concept

Abstract Background Not all patients with major depressive disorder (MDD) benefit from the US Food and Drug Administration‐approved use of repetitive transcranial magnetic stimulation (rTMS) at the dorsolateral prefrontal cortex. We may be undertreating depression with this one‐size‐fits‐all rTMS st...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Si Jie Tang, Jonas Holle, Nicholas B. Dadario, Olivia Lesslar, Charles Teo, Mark Ryan, Michael Sughrue, Jacky T. Yeung
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Wiley 2023-11-01
Cyfres:	Brain and Behavior
Pynciau:	connectomics functional MRI individualized major depressive disorder rTMS
Mynediad Ar-lein:	https://doi.org/10.1002/brb3.3268
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!